Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
DigitalBridge
DBRG
$2.95B
| $792K | ﹤0.01% |
57,793
-111,434
| -66% | -$1.68M |
|
2652
Protolabs
PRLB
$2.1B
| $791K | ﹤0.01% |
25,616
-8,106
| -24% | -$257K |
|
2653
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
| $791K | ﹤0.01% |
4,058
+3,721
| +1,104% | +$694K |
|
2654
Evertec
EVTC
$1.85B
| $790K | ﹤0.01% |
23,766
-35,027
| -60% | -$1.27M |
|
2655
Centrus Energy
LEU
$3.5B
| $789K | ﹤0.01% |
18,448
-6,234
| -25% | -$276K |
|
2656
CALL
Exelixis
EXEL
$13.1B
| $786K | ﹤0.01% |
35,000
| – | – |
|
2657
ATI
ATI
$30.5B
| $784K | ﹤0.01% |
14,146
-115,314
| -89% | -$6.46M |
|
2658
Carter's
CRI
$1.48B
| $784K | ﹤0.01% |
12,648
-27,631
| -69% | -$1.92M |
|
|
ZUO
2659
DELISTED
Zuora, Inc.
ZUO
| $784K | ﹤0.01% |
78,916
-106,262
| -57% | -$1.02M |
|
|
CFLT
2660
CALL
DELISTED
Confluent
CFLT
| $780K | ﹤0.01% |
26,400
-87,000
| -77% | -$2.5M |
|
2661
Virtu Financial
VIRT
$4.91B
| $778K | ﹤0.01% |
34,643
-34,980
| -50% | -$780K |
|
2662
Mirion Technologies
MIR
$3.74B
| $777K | ﹤0.01% |
72,392
-103,006
| -59% | -$1.09M |
|
|
GRFS
2663
Grifois
GRFS
$5.33B
| $776K | ﹤0.01% |
123,151
-449,163
| -78% | -$3.12M |
|
|
MAXN
2664
DELISTED
Maxeon Solar Technologies
MAXN
| $773K | ﹤0.01% |
9,062
+8,078
| +821% | +$1.71M |
|
2665
FS Bancorp
FSBW
$321M
| $769K | ﹤0.01% |
21,087
-2,303
| -10% | -$75.4K |
|
2666
Sana Biotechnology
SANA
$949M
| $768K | ﹤0.01% |
140,731
+24,720
| +21% | +$197K |
|
2667
StoneX
SNEX
$8.07B
| $767K | ﹤0.01% |
34,351
-53,085
| -61% | -$1.13M |
|
|
DAWN
2668
DELISTED
Day One Biopharmaceuticals
DAWN
| $766K | ﹤0.01% |
55,594
-11,872
| -18% | -$174K |
|
2669
Viridian Therapeutics
VRDN
$2.49B
| $766K | ﹤0.01% |
58,847
-65,301
| -53% | -$904K |
|
2670
Fortis
FTS
$28.6B
| $764K | ﹤0.01% |
19,681
+3,170
| +19% | +$125K |
|
2671
CALL
Zoom
ZM
$29.7B
| $764K | ﹤0.01% |
+12,900
| New | +$792K |
|
2672
Universal Insurance Holdings
UVE
$1.25B
| $763K | ﹤0.01% |
40,691
-7,218
| -15% | -$140K |
|
|
SCS
2673
DELISTED
Steelcase
SCS
| $761K | ﹤0.01% |
58,734
-47,651
| -45% | -$607K |
|
2674
CALL
Chegg
CHGG
$98.4M
| $758K | ﹤0.01% |
240,000
+200,000
| +500% | +$994K |
|
2675
Karyopharm Therapeutics
KPTI
$44.2M
| $758K | ﹤0.01% |
58,218
-1,303
| -2% | -$21.6K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.